Maier, Curtis C.
3396  Ergebnisse:
Personensuche X
?
1

Challenges and gaps in immunosafety evaluation of therapeut..:

Collinge, Mark ; Neff-LaFord, Haley ; Akella, Surekha...
Regulatory Toxicology and Pharmacology.  150 (2024)  - p. 105630 , 2024
 
?
3

In vivo biodistribution and pharmacokinetics of sotrovimab,..:

Aweda, Tolulope A. ; Cheng, Shih-Hsun ; Lenhard, Stephen C....
European Journal of Nuclear Medicine and Molecular Imaging.  50 (2022)  3 - p. 667-678 , 2022
 
?
4

Nonclinical safety assessment of engineered T cell therapie:

Lebrec, Herve ; Maier, Curtis C. ; Maki, Kazushige...
Regulatory Toxicology and Pharmacology.  127 (2021)  - p. 105064 , 2021
 
?
8

Biochemical features of anergic T cells:

Maier, Curtis C. ; Greene, Mark I.
Immunologic Research.  17 (1998)  1-2 - p. 133-140 , 1998
 
?
9

Unique molecular surface features ofin vivotolerized T cell:

Maier, Curtis C. ; Bhandoola, Avinash ; Borden, William...
Proceedings of the National Academy of Sciences.  95 (1998)  8 - p. 4499-4503 , 1998
 
?
10

Unique Molecular Surface Features of in vivo Tolerized T Ce..:

Maier, Curtis C. ; Bhandoola, Avinash ; Borden, William...
Proceedings of the National Academy of Sciences of the United States of America.  95 (1998)  8 - p. 4499-4503 , 1998
 
?
12

[22] Cloning and sequencing immunoglobulin and T-cell recep..:

, In: Methods in Neurosciences; Neuroimmunology,
Maier, Curtis C. ; Blalock, J. Edwin - p. 321-334 , 1995
 
1-15